DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,757,004 | -3.9% | 27,235 | -7.0% | 0.05% | +2.2% |
| Q2 2023 | $7,030,560 | -10.3% | 29,294 | -5.8% | 0.04% | -18.2% |
| Q1 2023 | $7,840,208 | -5.4% | 31,107 | -0.4% | 0.06% | -14.1% |
| Q4 2022 | $8,286,147 | +2.8% | 31,219 | 0.0% | 0.06% | 0.0% |
| Q3 2022 | $8,064,000 | -1.9% | 31,219 | -3.7% | 0.06% | -1.5% |
| Q2 2022 | $8,218,000 | -13.1% | 32,416 | +0.5% | 0.06% | +6.6% |
| Q1 2022 | $9,458,000 | -10.5% | 32,243 | +0.3% | 0.06% | -3.2% |
| Q4 2021 | $10,573,000 | +6.8% | 32,136 | -1.2% | 0.06% | +5.0% |
| Q3 2021 | $9,901,000 | +12.6% | 32,521 | -0.8% | 0.06% | +13.2% |
| Q2 2021 | $8,794,000 | +19.2% | 32,771 | 0.0% | 0.05% | +15.2% |
| Q1 2021 | $7,376,000 | +2.9% | 32,771 | +1.6% | 0.05% | +7.0% |
| Q4 2020 | $7,167,000 | +3.5% | 32,263 | +0.3% | 0.04% | -4.4% |
| Q3 2020 | $6,927,000 | +21.8% | 32,167 | 0.0% | 0.04% | +15.4% |
| Q2 2020 | $5,688,000 | +27.3% | 32,167 | -0.4% | 0.04% | 0.0% |
| Q1 2020 | $4,469,000 | -11.0% | 32,287 | -1.4% | 0.04% | +8.3% |
| Q4 2019 | $5,024,000 | -2.1% | 32,737 | -7.8% | 0.04% | -12.2% |
| Q3 2019 | $5,130,000 | -2.5% | 35,518 | -3.5% | 0.04% | +2.5% |
| Q2 2019 | $5,262,000 | +3.9% | 36,816 | -4.0% | 0.04% | +2.6% |
| Q1 2019 | $5,065,000 | +28.2% | 38,366 | +0.1% | 0.04% | +14.7% |
| Q4 2018 | $3,952,000 | -3.3% | 38,322 | +1.9% | 0.03% | +17.2% |
| Q3 2018 | $4,085,000 | +8.1% | 37,592 | -1.8% | 0.03% | +3.6% |
| Q2 2018 | $3,779,000 | -6.9% | 38,292 | -7.6% | 0.03% | -9.7% |
| Q1 2018 | $4,057,000 | -94.3% | 41,435 | -94.6% | 0.03% | -94.3% |
| Q4 2017 | $71,432,000 | -29.9% | 769,580 | -35.2% | 0.55% | -30.3% |
| Q3 2017 | $101,923,000 | +8.0% | 1,188,193 | +6.2% | 0.78% | -2.6% |
| Q2 2017 | $94,377,000 | -8.5% | 1,118,349 | -7.3% | 0.80% | -9.2% |
| Q1 2017 | $103,142,000 | +31.4% | 1,205,916 | +19.6% | 0.88% | +28.6% |
| Q4 2016 | $78,513,000 | -23.8% | 1,008,645 | -23.3% | 0.69% | -17.3% |
| Q3 2016 | $103,048,000 | -24.4% | 1,314,559 | -2.6% | 0.83% | -26.0% |
| Q2 2016 | $136,270,000 | +67.4% | 1,349,211 | +57.2% | 1.12% | +81.3% |
| Q1 2016 | $81,422,000 | +3301.1% | 858,341 | +3230.1% | 0.62% | +3775.0% |
| Q4 2015 | $2,394,000 | +5.5% | 25,775 | -3.2% | 0.02% | 0.0% |
| Q3 2015 | $2,269,000 | -0.4% | 26,624 | 0.0% | 0.02% | +14.3% |
| Q2 2015 | $2,279,000 | -98.4% | 26,624 | -98.4% | 0.01% | -98.3% |
| Q1 2015 | $140,024,000 | -2.8% | 1,649,279 | -1.9% | 0.81% | -4.8% |
| Q4 2014 | $144,125,000 | +13.2% | 1,681,546 | +0.3% | 0.85% | +9.1% |
| Q3 2014 | $127,333,000 | -3.7% | 1,675,876 | -0.2% | 0.78% | -1.3% |
| Q2 2014 | $132,259,000 | -11.2% | 1,679,907 | -15.4% | 0.79% | -11.7% |
| Q1 2014 | $148,913,000 | -5.9% | 1,985,513 | -3.1% | 0.89% | -4.3% |
| Q4 2013 | $158,212,000 | +10.1% | 2,049,378 | -1.1% | 0.93% | +1.4% |
| Q3 2013 | $143,674,000 | +7.4% | 2,072,619 | -1.9% | 0.92% | -0.2% |
| Q2 2013 | $133,800,000 | – | 2,113,750 | – | 0.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |